Form 4: Intra-Cellular Therapies CEO Sharon Mates Reports Stock Transactions
SEC Form 4 Filing
Sharon Mates, Chairman and CEO of Intra-Cellular Therapies, reports the vesting and subsequent tax withholding of shares related to restricted stock units.
Summary
- On March 6, 2025, Sharon Mates, Chairman and CEO of Intra-Cellular Therapies, exercised restricted stock units converting into 40,712 shares of common stock.
- The company withheld 19,848 shares to cover tax obligations at a price of $131.19 per share.
- Following these transactions, Mates directly owns 1,124,798 shares of common stock.
- On March 10, 2025, Mates exercised restricted stock units converting into 20,566 shares of common stock.
- The company withheld 10,129 shares to cover tax obligations at a price of $131.24 per share.
- Following these transactions, Mates directly owns 1,135,235 shares of common stock.
- The restricted stock units vest in three equal annual installments beginning on the first anniversary of the grant date.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock transactions by a company insider; it doesn't inherently indicate positive or negative sentiment.
Positives
- The vesting of restricted stock units indicates that Mates is meeting the conditions of her equity compensation plan.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transactions have a minor impact on the total number of outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/10/2022 | Reporting person was granted 61,696 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. |
| 03/06/2023 | Reporting person was granted 122,137 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. |
| 03/06/2025 | Sharon Mates exercised 40,712 restricted stock units and the company withheld 19,848 shares for tax obligations. |
| 03/10/2025 | Sharon Mates exercised 20,566 restricted stock units and the company withheld 10,129 shares for tax obligations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.